Showing results (3101-3110 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|March 14, 2014
Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancerEiji Iwama, Isamu Okamoto, Taishi Harada, et al.Oncotargets and Therapy|March 15, 2014
The relationship between intervention in the CD40 signal pathway and choroidal neovascularizationPeipei Zhang, Yan Su, Fang LiuOncotargets and Therapy|March 15, 2014
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case reportHideo Yuki, Takao Kamai, Keiichi Kubota, et al.Oncotargets and Therapy|April 22, 2014
Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapyXiaoliang Zhou, Hao Wang, Peiji Shi, et al.Oncotargets and Therapy|April 22, 2014
PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysisYi-Rong Liu, Yi-Zhou Jiang, Wen-Jia Zuo, et al.Oncotargets and Therapy|April 22, 2014
Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicityMoonkyoo Kong, Seong Eon Hong, Sung-Goo ChangOncotargets and Therapy|April 9, 2014
Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidityRobin A Laskey, Scott D Richard, Ashlee L Smith, et al.Oncotargets and Therapy|April 9, 2014
Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomasQuan Zhou, Jin Xu, Jiali Zhao, et al.Oncotargets and Therapy|March 26, 2014
Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motilityHuan-Yong Che, Hang-Yuan Guo, Xu-Wei Si, et al.Oncotargets and Therapy|March 28, 2014
Oncogene mutational profile in nasopharyngeal carcinomaZi-Chen Zhang, Sha Fu, Fang Wang, et al.Pageof 674